Chinese biotechnology company
Sinopharm Group
logo of Sinopharm Group (same as China National Pharmaceutical Group), with bilingual name on the right
Company type
public
ISIN CNE100000FN7 Industry
Pharmaceutical Founded Founder
China National Pharmaceutical Group Headquarters Sinopharm Plaza, , China
Area served
China Key people
Wei Yulin (Chairman) Chen Qiyu (Vice-Chairman) Li Zhiming (
President ) Revenue CN¥227.069
billion (2015) CN¥9.169 billion (2015) CN¥3.761 billion (2015)
Total assets CN¥138.267 billion (2015)
Total equity CN¥30.052 billion (2015)Owner Sinopharm Industrial Investment (56.79%)
Parent Sinopharm Industrial Investment
Subsidiaries
Sinopharm CNMC Footnotes / references in a consolidated basis; equity and profit excluded minority interests; in Hong Kong Financial Reporting Standards
[1]
Sinopharm Group Co., Ltd. is a Chinese
pharmaceutical company . The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of
state-owned enterprise
China National Pharmaceutical Group and
civilian-run enterprise
Fosun Pharmaceutical .
Its
H shares were listed on the
Hong Kong Stock Exchange in 2009,
[2] with its
IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the
A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016
Forbes Global 2000 list.
[3]
COVID-19 Vaccine development
The Sinopharm BIBP COVID-19 vaccine , also known as BBIBP-CorV ,
[4] the Sinopharm COVID-19 vaccine ,
[5] or BIBP vaccine ,
[5]
[6]
[7] is one of two
inactivated virus
COVID-19 vaccines developed by
Sinopharm . It completed
Phase III trials in
Argentina ,
Bahrain ,
Egypt ,
Morocco ,
Pakistan ,
Peru , and the
United Arab Emirates (UAE) with over 60,000 participants.
[8] The BIBP vaccine shares similar technology with
CoronaVac and
Covaxin , other inactivated virus vaccines for COVID-19.
[9]
Peer-reviewed results published in
JAMA of Phase III trials in
United Arab Emirates and
Bahrain showed that the BIBP vaccine is 78.1% effective against symptomatic cases and 100% against severe cases (21 cases in vaccinated group vs. 95 cases in placebo group).
[10] In December 2020, the UAE previously announced interim results showing 86% efficacy.
[11] While mRNA vaccines showed higher efficacy of over 90%, those present distribution challenges for some nations as they require deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures.
[12]
The BIBP vaccine is being used in vaccination campaigns by certain countries in Asia,
[13]
[14]
[15] Africa,
[16]
[17]
[18] South America,
[19]
[20]
[21] and Europe.
[22]
[23]
[24] Sinopharm was expected to produce one billion doses of the BIBP vaccine in 2021.
[25] On 7 May 2021, the
World Health Organization approved the vaccine for use in
COVAX .
[14]
[26]
See also
References
^
"2015 Annual Report" (PDF) . Sinopharm Group . Hong Kong Stock Exchange. 25 April 2016. Retrieved 22 November 2016 .
^
"China's Sinopharm gets OK for $1 bln HK IPO" . Reuters . 2009-07-29. Retrieved 2020-11-14 .
^
"Sinopharm Group" . Forbes . Retrieved 2020-11-14 .
^ Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. (January 2021).
"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial" . The Lancet. Infectious Diseases . 21 (1): 39–51.
doi :
10.1016/s1473-3099(20)30831-8 .
PMC
7561304 .
PMID
33069281 .
^
a
b
"The Sinopharm COVID-19 vaccine: What you need to know" . World Health Organization. 10 May 2021. Retrieved 5 July 2021 .
^ Nguyen S (5 June 2021).
"Coronavirus: Vietnam approves Sinopharm's vaccine, but will people take it?" . South China Morning Post . Retrieved 5 July 2021 .
^ Lahiri T, Li J (16 June 2021).
"What we now know about the efficacy of China's Covid-19 vaccines" . Quartz . Retrieved 5 July 2021 .
^
"China Sinopharm's coronavirus vaccine taken by about a million people in emergency use" . Reuters . 2020-11-19. Retrieved 2020-12-09 .
^ Corum, Jonathan; Zimmer, Carl (2021-04-26).
"How the Sinopharm Vaccine Works" . The New York Times .
ISSN
0362-4331 . Retrieved 2021-04-29 .
^ Kaabi, Nawal Al; Zhang, Yuntao; Xia, Shengli; et al. (May 26, 2021).
"Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial" . JAMA . 326 (1): 35–45.
doi :
10.1001/jama.2021.8565 .
PMC
8156175 .
PMID
34037666 .
^
"UAE: Ministry of Health announces 86 per cent vaccine efficacy" . gulfnews.com . 9 December 2020. Retrieved 2020-12-13 .
^
"China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says" . Bloomberg.com . 2020-12-09. Retrieved 2020-12-09 .
^ Liu R (2020-12-31).
"China gives its first COVID-19 vaccine approval to Sinopharm" . Reuters . Retrieved 2020-12-31 .
^
a
b Turak, Natasha (2021-01-18).
"The UAE is on track to have half its population vaccinated by the end of March" . CNBC . Retrieved 2021-01-21 .
^ Dawn.com (2021-02-02).
"PM Imran kicks off Pakistan's Covid-19 vaccination drive" . DAWN.COM . Retrieved 2021-02-03 .
^
"Sisi says Egypt to begin COVID-19 vaccinations on Sunday" .
Reuters . 2021-01-24. Retrieved 2021-01-24 .
^ Dumpis, Toms (2021-01-27).
"Morocco Receives Half a Million Doses of Chinese Sinopharm Vaccine" . Morocco World News . Retrieved 2021-01-28 .
^
"Zimbabwe starts administering China's Sinopharm vaccines" . thestar.com . 2021-02-18. Retrieved 2021-02-20 .
^
"Argentina autoriza la vacuna china Sinopharm para mayores de 60 años" . El Comercio . Retrieved 2021-03-26 .
^ Aquino, Marco (2021-02-10).
" 'The best shield': Peru launches inoculation drive with Sinopharm vaccine" . Reuters . Retrieved 2021-02-10 .
^
"Bolivia begins inoculation with Sinopharm jabs | The Star" . www.thestar.com.my . Retrieved 2021-02-28 .
^
"Serbia Becomes First European Nation To Use China's Sinopharm Vaccine" . Radio Free Europe/Radio Liberty . 20 January 2021. Retrieved 2021-01-21 .
^
"Hungary first EU nation to use China's Sinopharm vaccine against COVID" . euronews . 2021-02-24. Retrieved 2021-02-26 .
^
"Belarus begins COVID-19 vaccinations with Chinese shots" . eng.belta.by . 2021-03-15. Retrieved 2021-03-16 .
^
"Which companies will likely produce the most COVID-19 vaccine in 2021?" . Pharmaceutical Processing World . 2021-02-05. Retrieved 2021-02-28 .
^ Taylor, Adam (7 May 2021).
"WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine" .
The Washington Post . Retrieved 7 May 2021 .
External links